Eli Lilly Canada Inc. reported 4 lobbying communications with federal officials between Sep 8, 2026 and Sep 25, 2026.
Officials contacted: Samuel Millar (Assistant Deputy Minister); Rodrigo Arancibia (Senior Director); Paul Moen (Chief of Staff); Omar Rajabali (Director General); Nicholas Chesterley (Director General); Manuela Tomic (Senior Policy Advisor).
On the agenda: The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry; Pharmaceutical pricing policy arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB); Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.
